Ecological Validation and Reliability of Hexoskin Wearable Body Metrics Tool in Measuring Pre-exercise and Peak Heart Rate During Shuttle Run Test in Professional Handball Players.

The aim of the study was to assess the validity and reliability of wearable body metric Hexoskin "smart shirt" in measuring heart rate (HR) at pre-exercise and during peak effort in a field test incorporating vigorous movements of the upper body. Measurements were recorded simultaneously using the Hexoskin and Polar Team Pro. Nine male professional handball players (age: 21.8 ± 2.4 years; weight: 83 ± 10.26 kg; height: 1.81 ± 0.09 m; and BMI: 25.17 ± 2.23) volitionally participated in the study by completing two 400 m shuttle run test trials (10 shuttles), each separated by a 48 to 72 h recovery period. Results indicated significant correlations between Hexoskin and Polar Team Pro system in pre-exercise HR. Hexoskin provided erroneous measurements in four of the nine athletes during peak effort. Subsequent correction yielded no consistency between the Polar Team Pro system and Hexoskin between the first and the second trial. Hexoskin showed significant reliability in pre-exercise HR. However, Hexoskin picked up excessive artifact during vigorous physical activity in four of the nine athletes rendering the results in these cases useless. Nevertheless, in athletes where artifact was not an issue, ICC yielded a good estimate. The main findings indicate that Hexoskin has good validity and reliability in measuring pre-exercise HR in handball players and hence may be used with high confidence in slow motion activities. However, vigorous physical activity with jarring multidirectional upper body movements posed a challenge for Hexoskin.

Effect of Sufentanil and Fentanyl on Heart Rate and Blood Pressure Changes during Induction of Anesthesia / 대한마취과학회지

BACKGREOUND: The hemodynamic responses to laryngoscopy and endotracheal intubation, tachycardia and arterial hypertension, are well known and should be minimized. The purpose of this study is comparison of effects of low-dose sufentanil and fentanyl on the changes of blood pressure and heart rate due to laryngoscopy and endotracheal intubation. METHODS: The cardiovascular responses were measured and compared in 60 patients, between 20~65 years old, ASA class I or II, undergoing elective operation pretreated with normal saline (n=20, control group), fentanyl 3 microgram/kg (n=20, fentanyl group), and sufentanil 0.6 microgram/kg (n=20, sufentanil group), respectively. Anesthesia was induced intravenously with pentothal sodium 4~5 mg/kg and endotracheal intubation was conducted after injection of succinylcholine 1 mg/kg. The changes of systolic arterial pressure, mean arterial pressure, diastolic arterial pressure, heart rate, and SpO2 (saturation of arterial oxygen) were measured at postsedation with pentothal sodium, 30 seconds, 1 minute, and 3 minutes following intubation. The variables of each group were compared with preinduction baseline values and fentanyl and sufentanil groups were compared with control group. Data were analyzed for statistical significance using repeated measures of ANOVA (analysis of variance). P<0.05 was considered statistically significant. RESULTS: The systolic and mean arterial pressures at 30 seconds and 1 minute and diastolic arterial pressure at 30 seconds after laryngoscopy and intubation in sufentanil group were significantly lower than values of control group (p<0.01). The heart rates at 30 seconds and 1 minute were significantly attenuated compared with control group (p<0.05). The blood pressures and heart rates of fentanyl group at 30 seconds after intubation were significantly attenuated compared with control group (p<0.05). CONCLUSIONS: The results suggest that pretreatment of fentanyl 3 microgram/kg and sufentanil 0.6 microgram/kg is effective to prevent the elevation of blood pressures and heart rates, and sufentanil 0.6 microgram/kg is more effective than fentanyl 3 microgram/kg to attenuate the hemodynamic changes due to laryngoscopy and intubation.

Effects of Clonidine on Blood pressure and Heart rate, and Anesthetic Requirement During Laparoscopic Cholecystectomy / 대한마취과학회지

BACKGROUND: Laparoscopic cholecystectomy has become popular in the recent year. However, CO2 insufflation and patient's position changes during laparoscopic surgery can create severe hemodynamic changes, and increase anesthetic requirement. The major aim of this study is to assess the effect of oral clonidine on the cardiovascular lability during the operative and post-operative periods and enflurane requirement during operative period. METHODS: 43 patients(ASA I or II) undergoing elective laparoscopic cholecystectomy were selected for this study. The patients were randomly allocated into 3 groups: group 1(n=14) received no clonidine, group 2(n=15) 0.2 mg of clonidine and group 3(n=14) 0.3 mg of clonidine. Blood pressure and heart rate were continuously monitored during both the operative and post-operative periods. The enflurane concentration was also continuously adjusted to maintain blood pressure and heart rate within the range of 20% changes of baseline values. RESULTS: Since enflurane concentration was controlled to maintain systolic blood pressure within 20% of baseline values, there was no statistically significant difference in vital signs in the three groups during anesthesia. However, vital signs including systolic and diastolic blood pressure during their time in PACU (post anesthesia care unit) between the control and the clonidine treated groups were significantly different. The results of the blood pressure for the groups were found as follows. group 1) 134.9 +/-22.3 mmHg and 77.1 +/-12.4 mmHg, group 2) 116.8 +/-11.1 mmHg and 68.9 +/-12.2 mmHg and group 3) 113+/- 9.2 mmHg and 65.9+/- 9.2 mmHg for systolic and diastolic blood pressure respectively. Also, both the clonidine 0.2 mg and 0.3 mg treated groups, showed significantly decreased anesthetic requirement compared with the control group (P<0.05). There were dose dependent changes between 0.2 mg and 0.3 mg clonidine pretreated groups. CONCLUSIONS: Preoperative clonidine administration was effective in decreasing anesthetic supplement during laparoscopic cholecystectomy, and lessening the severity of hemodynamic changes during PACU.

The Effect of Continuous Intravenous Infusion of Esmolol on Heart Rate and Blood Pressure after Ketamine Induction and Endotracheal Intubation / 대한마취과학회지

BACKGROUND: This study was designed to evaluate the effect of continuous intravenous infusion of esmolol on the heart rate and blood pressure, after ketamine induction and endotracheal intubation. METHODS: With informed consent, forty patients with ASA physical status 1 were randomly divided into two groups. Esmolol group received the continuous intravenous infusion of esmolol (at 500 microgram/kg/min for 1 minute as a loading dose and at 300 microgram/kg/min until 7 minutes after endotracheal intubation as a maintenance dose) and saline group received normal saline at the same volume-rate. 2 mg/kg of ketamine and 0.15 mg/kg of vecuronium were given at 4 minutes after the test drugs. Intubation was performed at 3 minutes after the induction. The changes of blood pressure, heart rate and rate pressure product were measured at different time intervals (preinduction, preintubation, immediately after intubation and postintubation 1, 3, 5 and 7minutes). RESULTS: In the esmolol group, the changes of systolic blood pressure, diastolic blood pressure, heart rate and rate pressure product were significantly attenuated when compared with the saline group. The changes in heart rate at preintubation and intubation were not statistically significant when compared with the baseline value within the esmolol group. CONCLUSIONS: It is concluded that the infusion of esmolol attenuated the hemodynamic changes following ketamine induction and endotracheal intubation, but it is still needed to find the dosage of esmolol.

Oral Clonidine Blunts the Heart Rate Response to Intravenous Atropine in Adults / 대한마취과학회지

BACKGROUND: Clonidine, which is known to have analgesic and sedative properties, has recently been shown to be an effective preanesthetic medication in humans. The drug may cause side effects, including bradycardia and hypotension. This study was conducted to evaluate the ability of intravenous atropine to increase the heart rate (HR) in awake adults receiving clonidine preanesthetic medication. METHODS: We studied HR responses to intravenous atropine in 45 patients assigned randomly to either a control group, who received no medication (group 1, n=15), or clonidine groups, who received oral clonidine of 2~2.5 mcg/kg (group 2, n=15), or 4.5~5 mcg/kg (group 3, n=15) 90 min before scheduled induction of anesthesia. When HR and blood pressure had been confirmed to be stable in operating room, all patients received incremental doses of atropine, 2.5, 2.5 and 5 mcg/kg at 2-min intervals. The HR and mean arterial pressure were recorded at 1-min intervals. RESULTS: Before atropine injection, the HR decreased significantly (P<0.05) in group 3. The increases in HR in response to a cumulative dose of atropine 10 mcg/kg were 21+/-8, 17+/-7 and 7+/-5 beats/min (mean+/-SD) in group 1, 2 and 3, respectively (P<0.05). The positive chronotropic response to intravenous atropine was attenuated significantly only in group 3 (P<0.01). CONCLUSIONS: It was concluded that oral clonidine of 4.5~5 mcg/kg decreased HR significantly, and blunted the increase in HR after intravenous atropine in awake adults although oral clonidine of 2~2.5 mcg/kg did not.